Tag: Janssen-Cilag

Five pharmas fall foul of ABPI Code of Practice

by Selina McKee | Dec 14, 2016 | News | 0

A stream of breaches of the Association of the British Pharmaceutical Industry’s Code of Practice has seen five pharmaceutical companies – AstraZeneca, Gruenenthal, Janssen-Cilag, Boehringer Ingelheim and Eli Lilly – named and shamed in the British medical press.

J&J’s Darzalex improves outcomes in multiple myeloma trial

by Selina McKee | Jun 6, 2016 | News | 0

Adding Johnson & Johnson’s Darzalex to the standard regimen of Takeda’s Velcade and dexamethasone significantly improved outcomes for patients with recurrent or refractory multiple myeloma, show findings of a late-stage trial.